Macrotope, Inc. announced it raised $200,000 in an initial filing from an offering of $750,000

Company

Location

About

Macrotope applies decades of expertise in biophysics, biochemistry, protein engineering, and high-throughput antigen production to tackle complex immunological challenges. With proprietary technologies that enable the design of advanced antigens, Macrotope drives the development of vaccines and therapeutic antibodies by eliciting potent, durable, and diverse immune responses.